Description: Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.
Home Page: www.chr-hansen.com
Boege AllE 10-12
Horsholm,
2970
Denmark
Phone:
45 45 74 74 74
Officers
| Name | Title |
|---|---|
| Mr. Mauricio Graber | CEO, Pres & Member of Exec. Board |
| Ms. Lise Skaarup Mortensen | Exec. VP, CFO & Member of Exec. Board |
| Dr. Thomas Schafer Ph.D. | Chief Science Advisor |
| Mr. Torsten Steenholt | Exec. VP of Global Operations |
| Mr. Henrik Joerck Nielsen | Exec. VP & Chief Scientific Officer |
| Anders Mohr Christensen | VP Group Strategy & Investor Relations |
| Ms. Winnie Hoejvang Bugel | Exec. VP of Compliance & Corp. Affairs |
| Sanne Seyer-Hansen | Head of Media Relations |
| Ms. Alice Larsen | Exec. VP of HR |
| Mr. Laurent Hubert | VP & Head of Food, Beverage and Diagnostics |
Exchange: CO
Country: DK : Denmark
Currency: Danish krone (kr)
| Forward PE: | 29.4985 |
|---|---|
| Trailing PE: | 40.4717 |
| Price-to-Book MRQ: | 43.4449 |
| Price-to-Sales TTM: | 56.617 |
| IPO Date: | |
| Fiscal Year End: | August |
| Full Time Employees: | 3834 |